Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-011145
Filing Date
2023-06-15
Accepted
2023-06-15 16:50:49
Documents
3
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20230615x6k.htm 6-K 28493
2 EX-99.1 tmb-20230615xex99d1.htm EX-99.1 19346
3 GRAPHIC tmb-20230615xex99d1001.jpg GRAPHIC 7891
  Complete submission text file 0001558370-23-011145.txt   59927
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40241 | Film No.: 231018110
SIC: 2834 Pharmaceutical Preparations